Amino Health vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Amino Health provides a data-driven healthcare navigation platform that helps employees find high-quality, in-network providers using a 26B+ claims database; raised $70M+ total;
About
Amino Health is a digital health company founded in 2013 and headquartered in San Francisco, California, that helps employees and health plan members find high-quality, cost-effective in-network healthcare providers using data-driven recommendations. The platform is powered by a proprietary database of more than 26 billion de-identified medical claims, which enables Amino to estimate physician quality, specialty expertise, and patient cost outcomes based on actual historical treatment data rather than self-reported information or generic star ratings.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.